Abstract
Alterations of the Bruton's tyrosine kinase(Btk) gene are responsible for X-linked agammaglobulinemia (XLA). Although mutations in various regions were reported mainly in the Caucasian population, correlation between the locations of mutation and the clinical phenotypes remains unclear. We report 12 abnormalities of theBtk gene found in 12 unrelated families out of 14 XLA families in Japan and their clinical features. We utilized Southern blotting and single-strand conformation polymorphism (SSCP) analysis. Gene rearrangement in the kinase domain was identified in two patients by Southern blotting. Seven point mutations, two small deletions, and one small insertion were detected by SSCP and sequencing. The SSCP analysis also provided information about the carriers in these families. We found some clinical heterogeneity in the affected family members with the same gene mutation. Moreover, there is considerable inconsistency between the locations of gene aberrations and the immunological phenotypes. Some patients with a nonsense mutation, which may result in the lack of kinase domain, have detectable B cells and immunoglobulins. These identified alterations will provide valuable clues to theBtk protein function and the pathogenesis of XLA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aoki Y, Isselbacher KJ, Pillai S (1994) Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc Natl Acad Sci USA 91:10606–10609
Bradley LA, Sweatman AK, Lovering RC, Jones AM, Morgan G, Levinsky RJ, Kinnon C (1994) Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. Hum Mol Genet 3:79–83
Bruton OC (1952) Agammaglobulinemia. Pediatrics 9:722–728
Conley ME, Puck JM (1988) Carrier detection in typical and atypical X-linked agammaglobulinemia. J Pediatr 112:688–694
Conley ME, Fitch-Hilgenberg ME, Cleveland JL, Parolini O, Rohrer J (1994) Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet 3:1751–1756
Cooper DN, Krawczak M (1989) Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet 83:181–188
Eck MJ, Shoelson SE, Harrison SC (1993) Recognition of a highaffinity phosphotyrosyl peptide by the Ste homology-2 domain of p561ck. Nature 362:87–91
Gregory RJ, Kammermeyer KL, Vincent WS III, Wadsworth SG (1987) Primary sequence and developmental expression of a novel Drosophila melanogaster Ste gene. Mol Cell Biol 7:2119–2127
Hageman TL, Chen Y, Rosen FS, Kwan S (1994) Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia. Hum Mol Genet 3:1743–1749
Kawakami Y, Yao L, Miura T, Tsukada S, Witte ON, Kawakami T (1994) Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fe epsilon RI cross-linking. Mol Cell Biol 14:5108–5113
Kawamura M, Kikuchi A, Kobayashi S, Hanada R, Yamamoto K, Horibe K, Shikano T, Ueda K, Hayashi K, Sekiya T, Hayashi Y (1995) Mutations of the p53 gene and ras genes in childhood t(1:19)-acute lymphoblastic leukemia. Blood 85:2546–2552
Kikuchi A, Hayashi Y, Kobayashi S, Hanada R, Moriwaki K, Yamamoto K, Fujumoto J, Kaneko Y, Yamamori S (1993) Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma. Leukemia 7:933–938
Koch WJ, Inglese J, Stone WC, Lefkowitz RJ (1993) The binding site for the βγ subunits of heterotrimeric G proteins on the β-adrenergic receptor kinase. J Biol Chem 268:8256–8260
Komuro H, Hayashi Y, Kawamura M, Hayashi K, Kaneko Y, Kamoshita S, Hanada R, Yamamoto K, Hongo T, Tsuchida Y (1993) Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastoma. Cancer Res 53:5284–5288
Mano H, Mano K, Tang B, Koehler M, Yi T, Gilbert DJ, Jenkins NA, Copeland NG, Ihle JN (1993) Expression of novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near Kit. Oncogene 8:417–424
Miyasita T, Iwata T, Mizutani S, Kamoshita S, Kobayashi N (1992) Carrier detection in agammaglobulinemia by X chromosome inactivation analysis. Acta Paediatr Jpn 34:267–272
Musacchio A, Gibson T, Rice P, Thompson J, Saraste M (1993) The PH domain is a common piece in the structural patchwork of signalling proteins. Trends Biochem Sci 18:343–348
Ohta Y, Haire RN, Litman RT, Fu SM, Nelson RP, Kratz J, Komfeld SJ, Morena M, Good RA, Litman GW (1994) Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia. Proc Natl Acad Sci USA 91:9062–9066
Pearl ER, Vogler LB, Okos AJ, Crist WM, Lawton AR III, Cooper MD (1978) B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody deficiency states. J Immunol 120:1169–1175
Rosen FS, Cooper MD, Wedgewood RJP (1984) The primary immunodeficiency. N Engl J Med 311:235–242
Shimazu M, Nunoi H, Terasaki H, Ninomiya R, Iwata M, Kanegasaki S, Matsuda I (1995) Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome. Biochim Biophys Acta 1260:67–72
Siliciano JD, Morrow TA, Desiderio SV (1992) Itk, a T-cell specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci USA 89:11 194–11 198
Smith CIE, Baskin B, Humire-Greiff P, Zhou JN, Olsson PG, Maniar HS, Kjellen P, Lambris JD, Christensson B, Hammarström L, Bentley D, Vetrie D, Islam KB, Vorěchovsky I, Sideras P (1994) Expression of Burton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol 152:557–565
Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte ON (1993) Deficient expression of a B cell cytoplasmic tyrosine kinase in human Xlinked agammaglobulinemia. Cell 72:279–290
Tsukada S, Simon MI, Witte ON, Katz A (1994) Binding of βγ subunits heterotrimeric G proteins to the PH domain of Burton tyrosine kinase. Proc Natl Acad Sci USA 91:11256–11260
Vetrie D, Vorěchovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarström L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bently DR (1993) The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature 361:226–233
Waksman G, Kominas D, Robertson SC, Pant N, Baltimore D, Birge RB, Cowburn D, Hanafusa H, Mayer BJ, Overduin M (1992) Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358:646–653
Weers M de, Verschuren MC, Kraakman ME, Mensink RGJ, Schuurman RK, Dongan JJ van, Hendriks RW (1993) The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur J Immunol 23:3109–3114
Yao L, Kawakami Y, Kawakami T (1994) The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 91:9175–9179
Zhu Q, Zhang M, Winkelstein J, Chen S, Ochs HD (1994) Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families. Hum Mol Genet 3:1899–1900
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobayashi, S., Iwata, T., Saito, M. et al. Mutations of theBtk gene in 12 unrelated families with X-linked agammaglobulinemia in Japan. Hum Genet 97, 424–430 (1996). https://doi.org/10.1007/BF02267060
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02267060